Page last updated: 2024-08-25

honokiol and Angiogenesis, Pathologic

honokiol has been researched along with Angiogenesis, Pathologic in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (35.29)29.6817
2010's9 (52.94)24.3611
2020's2 (11.76)2.80

Authors

AuthorsStudies
Chen, J; Chen, L; Jie, S; Li, S; Liang, X; Luo, Y; Ma, L; Peng, A; Peng, M; Wang, T; Wang, X; Wei, Y; Zhu, W1
Chen, T; Cheng, X; Fan, L; Huang, Y; Qiao, Y; Shen, X; Wang, F; Wei, M; Yu, D1
Aghi, MK; Chandra, A; Chen, W; Diaz, AA; Garcia, JH; Gilbert, LA; Jahangiri, A; Jain, S; Joshi, RS; Kumar, S; Lin, JG; Müller, S; Nguyen, AT; Pereira, MP; Rick, JW; Shah, SS; Wadhwa, H; Weiss, J; Wolf, KJ; Yagnik, G1
Balan, M; Chakraborty, S; Flynn, E; Pal, S; Zurakowski, D1
Cheng, L; Ju, RJ; Li, CQ; Li, XT; Liu, S; Peng, XM; Qiu, X; Song, XL; Wang, T1
Bai, P; Bian, Y; Cheng, Z; Liang, L; Wan, J; Wang, F; Wang, S; Xue, F1
Kanjilal, D; Mukherji, M; Ponnaluri, VK; Vavilala, DT1
Mukherji, M; Subhani, S; Vavilala, DT1
Gao, X; Guo, G; Hu, X; Liu, X; Liu, Y; Mao, Q; Wang, X; Xu, G; You, C; Yu, T; Zhou, L1
Chen, L; Chen, X; Hou, W; Hu, J; Jiang, Q; Tang, M; Wang, X; Wei, Y; Wen, J; Yang, G; Yuan, Y; Zhong, Z; Zhou, H1
Chen, LJ; Fan, LY; Guo, WH; Hou, WL; Jiang, QQ; Wei, YQ; Yang, GL1
Chen, LJ; Chen, PL; Chen, X; Hou, WL; Hu, J; Liu, L; Tang, MH; Wang, XH; Wei, YQ; Yang, G; Zhang, F; Zhao, X1
Mitra, AK; Mukherji, M; Pal, D; Ponnaluri, VK; Vadlapatla, RK; Vavilala, DT1
Chen, YC; Cheng, HC; Lan, KH; Lee, WJ; Liao, KK; Liu, SH; Pan, HC; Peng, YC; Shen, CC; Sheu, ML; Wang, KB; Wu, SM1
Anderson, KC; Arbiser, J; Chauhan, D; Hamasaki, M; Hideshima, H; Hideshima, T; Ishitsuka, K; Kumar, S; Le Gouill, S; Podar, K; Raje, N; Richardson, P; Roccaro, AM; Shiraishi, N; Tamura, K; Yasui, H1
Arbiser, JL; Bhandarkar, S; Cance, WG; Funa, NS; Kurenova, EV; Reddy, K; Welsh, M; Yang, L1
Chen, L; Huang, C; Li, Z; Liu, Y; Pan, X; Wei, Y; Yin, R; Zhao, X1

Reviews

1 review(s) available for honokiol and Angiogenesis, Pathologic

ArticleYear
HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies.
    Angiogenesis, 2016, Volume: 19, Issue:3

    Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Anthracyclines; Biphenyl Compounds; Cardiac Glycosides; Humans; Hypoxia-Inducible Factor 1; Indazoles; Lignans; Models, Biological; Neoplasms; Neovascularization, Pathologic; Retinal Neovascularization; Vascular Endothelial Growth Factors

2016

Other Studies

16 other study(ies) available for honokiol and Angiogenesis, Pathologic

ArticleYear
Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship.
    Journal of medicinal chemistry, 2011, Oct-13, Volume: 54, Issue:19

    Topics: Allyl Compounds; Angiogenesis Inhibitors; Animals; Animals, Genetically Modified; Benzaldehydes; Biphenyl Compounds; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Embryo, Nonmammalian; Endothelial Cells; Endothelium, Vascular; Humans; In Vitro Techniques; Lignans; Magnolia; Neovascularization, Pathologic; Neovascularization, Physiologic; Structure-Activity Relationship; Zebrafish

2011
Honokiol inhibits interleukin-induced angiogenesis in the NSCLC microenvironment through the NF-κB signaling pathway.
    Chemico-biological interactions, 2023, Jan-25, Volume: 370

    Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Human Umbilical Vein Endothelial Cells; Humans; Interleukins; Lung Neoplasms; Neovascularization, Pathologic; NF-kappa B; Signal Transduction; Tumor Microenvironment; Vascular Endothelial Growth Factor A

2023
Clonal ZEB1-Driven Mesenchymal Transition Promotes Targetable Oncologic Antiangiogenic Therapy Resistance.
    Cancer research, 2020, 04-01, Volume: 80, Issue:7

    Topics: Adult; Aged; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biphenyl Compounds; Brain; Brain Neoplasms; Cell Hypoxia; Cell Line, Tumor; Chitinase-3-Like Protein 1; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Human Umbilical Vein Endothelial Cells; Humans; Lignans; Male; Middle Aged; Neoplasm Invasiveness; Neoplastic Stem Cells; Neovascularization, Pathologic; Tumor Microenvironment; Up-Regulation; Xenograft Model Antitumor Assays; Young Adult; Zinc Finger E-box-Binding Homeobox 1

2020
Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth.
    Scientific reports, 2017, 07-19, Volume: 7, Issue:1

    Topics: Animals; Apoptosis; Biphenyl Compounds; Calcineurin Inhibitors; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Heme Oxygenase-1; Hepatocyte Growth Factor; Human Umbilical Vein Endothelial Cells; Humans; Kidney Neoplasms; Lignans; Mice, Nude; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Proto-Oncogene Proteins c-met; ras Proteins

2017
Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels.
    Journal of drug targeting, 2018, Volume: 26, Issue:9

    Topics: Animals; Biphenyl Compounds; Breast Neoplasms; Cations; Daunorubicin; Female; Humans; Hyaluronic Acid; Lignans; Liposomes; MCF-7 Cells; Mice; Neovascularization, Pathologic

2018
[Honokiol inhibits the invasion and angiogenesis of U937 leukemia cells].
    Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2014, Volume: 30, Issue:2

    Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Lignans; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1

2014
Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases.
    PloS one, 2014, Volume: 9, Issue:11

    Topics: Angiogenesis Inhibitors; Biphenyl Compounds; Cell Line; Cell Movement; Cell Proliferation; Endothelium, Vascular; Eye Diseases; HeLa Cells; Humans; Hypoxia-Inducible Factor 1; Lignans; Luciferases; Neovascularization, Pathologic; Retinal Pigment Epithelium

2014
Enhancing the anti-glioma therapy of doxorubicin by honokiol with biodegradable self-assembling micelles through multiple evaluations.
    Scientific reports, 2017, 02-27, Volume: 7

    Topics: Animals; Antineoplastic Agents; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Doxorubicin; Drug Carriers; Drug Liberation; Drug Synergism; Humans; Lignans; Micelles; Nanoparticles; Neovascularization, Pathologic; Polyesters; Polyethylene Glycols; X-Ray Diffraction; Xenograft Model Antitumor Assays; Zebrafish

2017
Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
    Phytotherapy research : PTR, 2008, Volume: 22, Issue:8

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Combinations; Drug Screening Assays, Antitumor; Drug Synergism; Drugs, Chinese Herbal; Female; Lignans; Liposomes; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Xenograft Model Antitumor Assays

2008
Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model.
    BMC cancer, 2008, Aug-16, Volume: 8

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cisplatin; Humans; In Situ Nick-End Labeling; Lignans; Liposomes; Lung Neoplasms; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Plant Extracts; Platelet Endothelial Cell Adhesion Molecule-1

2008
Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity.
    Experimental & molecular medicine, 2008, Dec-31, Volume: 40, Issue:6

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biphenyl Compounds; Carcinoma, Lewis Lung; Cell Cycle; Cell Line, Tumor; Combined Modality Therapy; Humans; Lignans; Liposomes; Lung Neoplasms; Magnolia; Mice; Neoplasm Transplantation; Neovascularization, Pathologic; Radiation Tolerance; Transplantation, Heterologous

2008
Honokiol inhibits HIF pathway and hypoxia-induced expression of histone lysine demethylases.
    Biochemical and biophysical research communications, 2012, Jun-08, Volume: 422, Issue:3

    Topics: Angiogenesis Inhibitors; Biphenyl Compounds; Cell Hypoxia; Cell Line; Cell Line, Tumor; Gene Expression; Histone Demethylases; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Lignans; Neovascularization, Pathologic; Oxygen

2012
Calpain/SHP-1 interaction by honokiol dampening peritoneal dissemination of gastric cancer in nu/nu mice.
    PloS one, 2012, Volume: 7, Issue:8

    Topics: Animals; Apoptosis; Biphenyl Compounds; Calpain; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Human Umbilical Vein Endothelial Cells; Humans; Lignans; Mice; Neovascularization, Pathologic; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 6; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms; Up-Regulation; Xenograft Model Antitumor Assays

2012
Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis.
    Blood, 2005, Sep-01, Volume: 106, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Bone Marrow Cells; Caspases; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Endothelial Cells; Humans; Insulin-Like Growth Factor I; Interleukin-6; Lignans; Multiple Myeloma; Neovascularization, Pathologic; Stromal Cells; Structure-Activity Relationship

2005
Shb gene knockdown increases the susceptibility of SVR endothelial tumor cells to apoptotic stimuli in vitro and in vivo.
    The Journal of investigative dermatology, 2008, Volume: 128, Issue:3

    Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Cisplatin; Endothelial Cells; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Protein-Tyrosine Kinases; Hemangiosarcoma; In Vitro Techniques; Lignans; Mice; Mice, Nude; Mutagenesis; Neoplasm Transplantation; Neovascularization, Pathologic; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Staurosporine

2008
Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells.
    European journal of obstetrics, gynecology, and reproductive biology, 2008, Volume: 140, Issue:1

    Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Biphenyl Compounds; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Lignans; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms

2008